Guidelines for the diagnosis and treatment of fibromyalgia syndrome

Title: Guidelines for the diagnosis and treatment of fibromyalgia syndrome
Edition: Original
Classification: Standard guideline
Field: Diagnosis and Management
Countries and regions: China
Guidelines users: First-line Chinese medicine doctors, western medicine doctors, rheumatologists in the field of integrated Chinese and Western medicine and professionals related to the diagnosis and treatment of fibromyalgia syndrome.
Evidence classification method:
Development unit: The Guang 'anmen Hospital, China Academy of Chinese Medical Sciences
Registration time: 2020-10-21
Registration number: IPGRP-2020CN160
Purpose of the guideline: In order to further enhance clinical attention to FMS and guide doctors to conduct standardized management of FMS more effectively, the expert group formulated the Fibromyalgia Syndrome Diagnosis and Treatment Guidelines.This guide only represents the views of the joint consensus group, and has certain reference value to standardize the diagnosis and treatment of integrated Traditional Chinese and Western medicine.The aim is to promote clinicians in rheumatology, pain, psychology, neurology and other relevant departments to attach great importance to the comprehensive management of FMS and the recognition and intervention of early FMS symptoms, early screening, early assessment, early intervention and early treatment, so as to improve the quality of life of patients.